Table of Content

1 INTRODUCTION 20
1.1 OBJECTIVES OF THE STUDY 20
1.2 MARKET DEFINITION 20
1.3 MARKET SCOPE 21
1.3.1 MARKETS COVERED 21
1.3.2 YEARS CONSIDERED FOR THE STUDY 22
1.4 CURRENCY 22
1.5 LIMITATIONS 22
1.6 STAKEHOLDERS 23

2 RESEARCH METHODOLOGY 24
2.1 RESEARCH DATA 24
2.1.1 SECONDARY DATA 25
2.1.1.1 Key data from secondary sources 26
2.1.2 PRIMARY DATA 26
2.1.2.1 Breakdown of primaries 27
2.1.2.2 Key data from primary sources 27
2.2 MARKET SIZE ESTIMATION 28
2.2.1 PRODUCT-BASED MARKET ESTIMATION 28
2.2.2 END USER-BASED MARKET ESTIMATION 29
2.3 MARKET BREAKDOWN & DATA TRIANGULATION 31
2.4 ASSUMPTIONS FOR THE STUDY 32

3 EXECUTIVE SUMMARY 33

4 PREMIUM INSIGHTS 36
4.1 PATIENT BLOOD MANAGEMENT MARKET OVERVIEW 36
4.2 PATIENT BLOOD MANAGEMENT MARKET, BY PRODUCT 37
4.3 PATIENT BLOOD MANAGEMENT MARKET, BY END USER 37
4.4 PATIENT BLOOD MANAGEMENT MARKET: REGIONAL GROWTH FORECASTS 38

5 MARKET OVERVIEW 39
5.1 INTRODUCTION 39
5.2 MARKET DYNAMICS 39
5.2.1 DRIVERS 40
5.2.1.1 Increasing demand for donated blood 40
5.2.1.2 Increasing number of blood donations and blood donors 41
5.2.1.3 Rising prevalence of target diseases 41
5.2.1.4 Regulatory guidelines for safe blood transfusion 42
5.2.1.5 Technological advancements in the patient blood management industry 44
5.2.2 RESTRAINTS 45
5.2.2.1 High cost associated with automated systems 45
5.2.3 OPPORTUNITIES 45
5.2.3.1 Market penetration opportunities in developing countries 45
5.2.3.2 Growing awareness regarding the safety of donated blood 46

6 PATIENT BLOOD MANAGEMENT MARKET, BY PRODUCT 47
6.1 INTRODUCTION 48
6.2 INSTRUMENTS 48
6.2.1 BLOOD PROCESSING DEVICES 49
6.2.1.1 Blood cell processors 50
6.2.1.1.1 Technological advancements in centrifugation systems might replace blood cell processors in the near future 50
6.2.1.2 Centrifuges 51
6.2.1.2.1 Longer lifespan of centrifuge systems to limit the growth of this segment 51
6.2.2 BLOOD TRANSFUSION DEVICES 52
6.2.2.1 Apheresis machines 53
6.2.2.1.1 Favorable reimbursement for therapeutic apheresis procedures to support market growth 53
6.2.2.2 Cell salvage systems 54
6.2.2.2.1 High cost of cell salvage systems as well as the dearth of trained professionals to restrain market growth 54
6.2.3 BLOOD CULTURE SCREENING DEVICES 55
6.2.3.1 Automated blood culture systems 56
6.2.3.1.1 Automated blood culture systems segment to witness higher growth during the forecast period 56
6.2.3.2 Supporting laboratory equipment 57
6.2.3.2.1 Growing automation to support the adoption of these equipment among end users 57
6.2.4 DIAGNOSTIC & TESTING INSTRUMENTS 57
6.2.4.1 PCR instruments 58
6.2.4.1.1 Significant adoption of RT-PCR to fuel market growth 58
6.2.4.2 Hematology analyzers 59
6.2.4.2.1 Technological advancements to support market growth 59
6.2.4.3 NGS platforms 60
6.2.4.3.1 RNA-Seq is an emerging approach for HIV testing 60
6.2.4.4 Blood grouping analyzers 61
6.2.4.4.1 Increasing adoption of blood grouping analyzers by blood banks to support market growth 61
6.2.4.5 Other instruments 62
6.2.5 BLOOD STORAGE DEVICES 63
6.2.5.1 Medical refrigerators 64
6.2.5.1.1 Medical refrigerators accounted for the largest share of the blood storage devices market in 2018 64
6.2.5.2 Medical freezers 64
6.2.5.2.1 Technological advancements to fuel market growth 64
6.3 ACCESSORIES 65
6.3.1 SYRINGES & NEEDLES 67
6.3.1.1 Easy availability and low cost of syringes and needles driving their adoption 67
6.3.2 VIALS & TUBES 67
6.3.2.1 Easier sample collection driving the adoption of vials and tubes 67
6.3.3 BLOOD BAGS 68
6.3.3.1 Increasing number of blood donations to support market growth 68
6.3.4 OTHER ACCESSORIES 69
6.4 REAGENTS AND KITS 69
6.4.1 BLOOD CULTURE MEDIA 71
6.4.1.1 A wide range of blood culture media are offered by companies 71
6.4.2 BLOOD TYPING REAGENTS 71
6.4.2.1 Mandatory use of ABO test prior to blood transfusion A major factor supporting market growth 71
6.4.3 SLIDE STAINING REAGENTS 72
6.4.3.1 Rising applications of staining techniques to support market growth 72
6.4.4 ASSAY KITS 73
6.4.4.1 Growing adoption of NAT tests across the globe to support market growth 73
6.4.5 OTHER REAGENTS 74
6.5 SOFTWARE 75
6.5.1 BLOOD BANK AND TRANSFUSION MANAGEMENT SOFTWARE 76
6.5.1.1 This software segment to register the highest growth rate over the forecast period 76
6.5.2 OTHER SOFTWARE 77

7 PATIENT BLOOD MANAGEMENT MARKET, BY COMPONENT 78
7.1 INTRODUCTION 79
7.2 WHOLE BLOOD 79
7.2.1 GROWING DISEASE INCIDENCE AND RISING SURGICAL VOLUMES ARE DRIVING THE DEMAND FOR WHOLE BLOOD UNITS 79
7.3 BLOOD COMPONENTS 80
7.3.1 EXPANDING APPLICATIONS OF BLOOD PLASMA AND PLATELETS TO SUPPORT MARKET GROWTH 80

8 PATIENT BLOOD MANAGEMENT MARKET, BY END USER 82
8.1 INTRODUCTION 83
8.2 BLOOD BANKS 83
8.2.1 HIGH DEMAND FOR SAFE BLOOD IS DRIVING THE GROWTH OF THIS END-USER SEGMENT 83
8.3 HOSPITALS 84
8.3.1 LARGE VOLUME OF SURGICAL PROCEDURES PERFORMED IN HOSPITALSMAJOR FACTOR DRIVING THE GROWTH OF THIS END-USER SEGMENT 84

9 PATIENT BLOOD MANAGEMENT MARKET, BY REGION 85
9.1 INTRODUCTION 86
9.2 NORTH AMERICA 87
9.2.1 US 90
9.2.1.1 The US dominates the patient blood management market due to the presence of well-developed healthcare infrastructure & growing adoption of advanced technologies 90
9.2.2 CANADA 92
9.2.2.1 Increasing number of surgical procedures performed in the country to drive the market for patient blood management products 92
9.3 EUROPE 95
9.3.1 GERMANY 98
9.3.1.1 Rising number of trauma cases and accidents to support market growth 98
9.3.2 UK 100
9.3.2.1 Rising number of road traffic accidents will support the growth of this market 100
9.3.3 FRANCE 102
9.3.3.1 Rising prevalence of blood disorders to support market growth in France 102
9.3.4 ITALY 104
9.3.4.1 Increasing awareness about safe blood transfusion will drive market growth 104
9.3.5 SPAIN 106
9.3.5.1 Government mandates to deliver safe blood for transfusion to support market growth 106
9.3.6 REST OF EUROPE 108
9.4 ASIA PACIFIC 110
9.4.1 JAPAN 114
9.4.1.1 Well-developed healthcare system and favorable reimbursement policy in the country to support market growth 114
9.4.2 CHINA 116
9.4.2.1 Market in China is estimated to grow at a high rate during the forecast period 116
9.4.3 INDIA 118
9.4.3.1 Favorable government initiatives to support market growth 118
9.4.4 AUSTRALIA 120
9.4.4.1 Presence of a highly developed healthcare system to contribute to market growth 120
9.4.5 SOUTH KOREA 122
9.4.5.1 Implementation of favorable government initiatives to support market growth 122
9.4.6 REST OF ASIA PACIFIC 124
9.5 LATIN AMERICA 126
9.5.1 BRAZIL 128
9.5.1.1 Growing medical tourism to support market growth in Brazil 128
9.5.2 MEXICO 130
9.5.2.1 Lack of awareness about blood donations to hamper market growth 130
9.5.3 REST OF LATIN AMERICA 132
9.6 MIDDLE EAST & AFRICA 134
10 COMPETITIVE LANDSCAPE 137
10.1 OVERVIEW 137
10.2 MARKET RANKING ANALYSIS, 2018 138
10.3 COMPETITIVE SCENARIO 139
10.3.1 PARTNERSHIPS, AGREEMENTS, AND COLLABORATIONS (2017–2019) 139
10.3.2 PRODUCT LAUNCHES (2017–2019) 140
10.3.3 EXPANSIONS (2017–2019) 140
10.3.4 ACQUISITIONS (2017–2019) 140
10.4 COMPETITIVE LEADERSHIP MAPPING (2019) 141
10.4.1 VENDOR INCLUSION CRITERIA 141
10.4.2 VISIONARY LEADERS 141
10.4.3 INNOVATORS 141
10.4.4 DYNAMIC DIFFERENTIATORS 141
10.4.5 EMERGING COMPANIES 141
11 COMPANY PROFILES 143
(Business Overview, Products Offered, Recent Developments, MnM View)*
11.1 ABBOTT LABORATORIES 143
11.2 ASAHI KASEI MEDICAL CO., LTD. (A SUBSIDIARY OF ASAHI KASEI CORPORATION) 146
11.3 B. BRAUN MELSUNGEN AG 148
11.4 BIOMRIEUX SA 150
11.5 BIO-RAD LABORATORIES, INC. 153
11.6 DANAHER CORPORATION 156
11.7 F. HOFFMANN-LA ROCHE LTD. 159
11.8 FRESENIUS SE & CO. KGAA 163
11.9 GRIFOLS, S.A. 166
11.10 HAEMONETICS CORPORATION 169
11.11 IMMUCOR, INC. 172
11.12 KANEKA CORPORATION 175
11.13 LIVANOVA PLC 177
11.14 MACOPHARMA 178
11.15 TERUMO CORPORATION 179
11.16 OTHER COMPANIES 183
11.16.1 MEDIWARE INFORMATION SYSTEMS 183
11.16.2 KAWASUMI LABORATORIES, INC. 184
11.16.3 HAIER BIOMEDICAL 185
11.16.4 DIATRON 186
11.16.5 BAG DIAGNOSTICS GMBH 187
*Business Overview, Products Offered, Recent Developments, MnM View might not be captured in case of unlisted companies.
12 APPENDIX 188
12.1 DISCUSSION GUIDE 188
12.2 KNOWLEDGE STORE:  193
12.3 AVAILABLE CUSTOMIZATIONS 195
12.4 RELATED REPORTS 195
12.5 AUTHOR DETAILS 196



List of Figures



FIGURE 1 PATIENT BLOOD MANAGEMENT MARKET: RESEARCH METHODOLOGY STEPS 24
FIGURE 2 RESEARCH DESIGN 25
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION AND REGION 27
FIGURE 4 PATIENT BLOOD MANAGEMENT MARKET: PRODUCT-BASED ESTIMATION 29
FIGURE 5 PATIENT BLOOD MANAGEMENT MARKET: END USER-BASED ESTIMATION 30
FIGURE 6 PATIENT BLOOD MANAGEMENT MARKET: DATA TRIANGULATION 31
FIGURE 7 PATIENT BLOOD MANAGEMENT MARKET SHARE, BY PRODUCT, 2019 VS. 2024 33
FIGURE 8 PATIENT BLOOD MANAGEMENT MARKET, BY COMPONENT 2019 VS. 2024 (USD MILLION) 34
FIGURE 9 PATIENT BLOOD MANAGEMENT MARKET, BY END USER 2019 VS. 2024 (USD MILLION) 34
FIGURE 10 PATIENT BLOOD MANAGEMENT MARKET, BY REGION 35
FIGURE 11 INCREASING DEMAND FOR DONATED BLOOD TO DRIVE MARKET GROWTH 36
FIGURE 12 INSTRUMENTS SEGMENT TO DOMINATE THE PATIENT BLOOD MANAGEMENT PRODUCTS MARKET DURING THE FORECAST PERIOD 37
FIGURE 13 BLOOD BANKS ARE THE LARGEST END USERS OF
PATIENT BLOOD MANAGEMENT PRODUCTS 37
FIGURE 14 APAC MARKET TO WITNESS THE HIGHEST GROWTH DURING
THE FORECAST PERIOD (2019–2024) 38
FIGURE 15 PATIENT BLOOD MANAGEMENT MARKET: DRIVERS, RESTRAINTS, AND OPPORTUNITIES 39
FIGURE 16 RATE OF ROAD TRAFFIC DEATHS PER 100,000 POPULATION, 2013 VS. 2016 40
FIGURE 17 NORTH AMERICA: PATIENT BLOOD MANAGEMENT MARKET SNAPSHOT 87
FIGURE 18 CANADA: NUMBER OF SURGICAL PROCEDURES, 2014–2017 93
FIGURE 19 ASIA PACIFIC: PATIENT BLOOD MANAGEMENT MARKET SNAPSHOT 111
FIGURE 20 KEY PLAYERS ADOPTED ORGANIC AS WELL AS INORGANIC GROWTH STRATEGIES BETWEEN 2017 AND 2019 137
FIGURE 21 PATIENT BLOOD MANAGEMENT MARKET RANKING ANALYSIS BY KEY PLAYER, 2018 138
FIGURE 22 PATIENT BLOOD MANAGEMENT SOFTWARE MARKET RANKING ANALYSIS BY KEY PLAYER, 2018 139
FIGURE 23 GLOBAL PATIENT BLOOD MANAGEMENT MARKET: COMPETITIVE LEADERSHIP MAPPING, 2018 142
FIGURE 24 ABBOTT LABORATORIES: COMPANY SNAPSHOT 143
FIGURE 25 ASAHI KASEI CORPORATION: COMPANY SNAPSHOT 146
FIGURE 26 B. BRAUN MELSUNGEN AG: COMPANY SNAPSHOT 148
FIGURE 27 BIOMRIEUX SA: COMPANY SNAPSHOT 150
FIGURE 28 BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT 153
FIGURE 29 DANAHER CORPORATION: COMPANY SNAPSHOT 156
FIGURE 30 F. HOFFMANN-LA ROCHE LTD.: COMPANY SNAPSHOT 159
FIGURE 31 FRESENIUS SE & CO. KGAA: COMPANY SNAPSHOT 163
FIGURE 32 GRIFOLS, S.A.: COMPANY SNAPSHOT 166
FIGURE 33 HAEMONETICS CORPORATION: COMPANY SNAPSHOT 169
FIGURE 34 KANEKA CORPORATION: COMPANY SNAPSHOT 175
FIGURE 35 LIVANOVA PLC: COMPANY SNAPSHOT 177
FIGURE 36 TERUMO CORPORATION: COMPANY SNAPSHOT 179

 

List of Tables



TABLE 1 LEUKEMIA INCIDENCE AND PREVALENCE, BY COUNTRY, 2018 42
TABLE 2 PATIENT BLOOD MANAGEMENT MARKET, BY PRODUCT 2017–2024 (USD MILLION) 48
TABLE 3 PATIENT BLOOD MANAGEMENT INSTRUMENTS MARKET, BY TYPE 2017–2024 (USD MILLION) 48
TABLE 4 PATIENT BLOOD MANAGEMENT INSTRUMENTS MARKET, BY REGION 2017–2024 (USD MILLION) 49
TABLE 5 INSTRUMENTS MARKET SPLIT, BY COMPONENT 49
TABLE 6 INSTRUMENTS MARKET SPLIT, BY END USER 49
TABLE 7 BLOOD PROCESSING DEVICES MARKET, BY TYPE, 2017–2024 (USD MILLION) 50
TABLE 8 BLOOD PROCESSING DEVICES MARKET, BY REGION, 2017–2024 (USD MILLION) 50
TABLE 9 BLOOD PROCESSING DEVICES MARKET FOR BLOOD CELL PROCESSORS BY REGION, 2017–2024 (USD MILLION) 51
TABLE 10 BLOOD PROCESSING DEVICES MARKET FOR CENTRIFUGES, BY REGION 2017–2024 (USD MILLION) 52
TABLE 11 BLOOD TRANSFUSION DEVICES MARKET, BY TYPE, 2017–2024 (USD MILLION) 52
TABLE 12 BLOOD TRANSFUSION DEVICES MARKET, BY REGION, 2017–2024 (USD MILLION) 52
TABLE 13 MEDICARE UNADJUSTED APC PAYMENT RATES FOR TRANSFUSION PROCEDURES AND THERAPEUTIC APHERESIS, 2019 53
TABLE 14 BLOOD TRANSFUSION DEVICES MARKET FOR APHERESIS MACHINES BY REGION, 2017–2024 (USD MILLION) 54
TABLE 15 BLOOD TRANSFUSION DEVICES MARKET FOR CELL SALVAGE SYSTEMS BY REGION, 2017–2024 (USD MILLION) 55
TABLE 16 BLOOD CULTURE SCREENING DEVICES MARKET, BY TYPE 2017–2024 (USD MILLION) 55
TABLE 17 BLOOD CULTURE SCREENING DEVICES MARKET, BY REGION 2017–2024 (USD MILLION) 56
TABLE 18 BLOOD CULTURE SCREENING DEVICES MARKET FOR AUTOMATED BLOOD CULTURE SYSTEMS, BY REGION, 2017–2024 (USD MILLION) 56
TABLE 19 BLOOD CULTURE SCREENING DEVICES MARKET FOR SUPPORTING LABORATORY EQUIPMENT, BY REGION, 2017–2024 (USD MILLION) 57
TABLE 20 DIAGNOSTIC & TESTING INSTRUMENTS MARKET, BY TYPE 2017–2024 (USD MILLION) 58
TABLE 21 DIAGNOSTIC & TESTING INSTRUMENTS MARKET, BY REGION 2017–2024 (USD MILLION) 58
TABLE 22 DIAGNOSTIC & TESTING INSTRUMENTS MARKET FOR PCR INSTRUMENTS BY REGION, 2017–2024 (USD MILLION) 59
TABLE 23 DIAGNOSTIC & TESTING INSTRUMENTS MARKET FOR HEMATOLOGY ANALYZERS, BY REGION, 2017–2024 (USD MILLION) 60
TABLE 24 DIAGNOSTIC & TESTING INSTRUMENTS MARKET FOR NGS PLATFORMS BY REGION, 2017–2024 (USD MILLION) 61
TABLE 25 DIAGNOSTIC & TESTING INSTRUMENTS MARKET FOR BLOOD GROUPING ANALYZERS, BY REGION, 2017–2024 (USD MILLION) 62
TABLE 26 DIAGNOSTIC & TESTING INSTRUMENTS MARKET FOR OTHER INSTRUMENTS BY REGION, 2017–2024 (USD MILLION) 62
TABLE 27 BLOOD STORAGE DEVICES MARKET, BY TYPE, 2017–2024 (USD MILLION) 63
TABLE 28 BLOOD STORAGE DEVICES MARKET, BY REGION, 2017–2024 (USD MILLION) 63
TABLE 29 BLOOD STORAGE DEVICES MARKET FOR MEDICAL REFRIGERATORS, BY REGION, 2017–2024 (USD MILLION) 64
TABLE 30 BLOOD STORAGE DEVICES MARKET FOR MEDICAL FREEZERS, BY REGION 2017–2024 (USD MILLION) 65
TABLE 31 PATIENT BLOOD MANAGEMENT ACCESSORIES MARKET, BY TYPE 2017–2024 (USD MILLION) 65
TABLE 32 PATIENT BLOOD MANAGEMENT ACCESSORIES MARKET, BY REGION 2017–2024 (USD MILLION) 66
TABLE 33 ACCESSORIES MARKET SPLIT, BY COMPONENT 66
TABLE 34 ACCESSORIES MARKET SPLIT, BY END USER 66
TABLE 35 PATIENT BLOOD MANAGEMENT ACCESSORIES MARKET FOR SYRINGES & NEEDLES, BY REGION, 2017–2024 (USD MILLION) 67
TABLE 36 PATIENT BLOOD MANAGEMENT ACCESSORIES MARKET FOR VIALS & TUBES BY REGION, 2017–2024 (USD MILLION) 68
TABLE 37 PATIENT BLOOD MANAGEMENT ACCESSORIES MARKET FOR BLOOD BAGS BY REGION, 2017–2024 (USD MILLION) 68
TABLE 38 OTHER PATIENT BLOOD MANAGEMENT ACCESSORIES MARKET, BY REGION, 2017–2024 (USD MILLION) 69
TABLE 39 PATIENT BLOOD MANAGEMENT REAGENTS AND KITS MARKET, BY TYPE 2017–2024 (USD MILLION) 69
TABLE 40 PATIENT BLOOD MANAGEMENT REAGENTS AND KITS MARKET, BY REGION 2017–2024 (USD MILLION) 70
TABLE 41 REAGENTS AND KITS MARKET SPLIT, BY COMPONENT 70
TABLE 42 REAGENTS AND KITS MARKET SPLIT, BY END USER 70
TABLE 43 PATIENT BLOOD MANAGEMENT MARKET FOR BLOOD CULTURE MEDIA BY REGION, 2017–2024 (USD MILLION) 71
TABLE 44 PATIENT BLOOD MANAGEMENT MARKET FOR BLOOD TYPING REAGENTS BY REGION, 2017–2024 (USD MILLION) 72
TABLE 45 PATIENT BLOOD MANAGEMENT MARKET FOR SLIDE STAINING REAGENTS BY REGION, 2017–2024 (USD MILLION) 72
TABLE 46 PATIENT BLOOD MANAGEMENT MARKET FOR ASSAY KITS, BY REGION 2017–2024 (USD MILLION) 74
TABLE 47 PATIENT BLOOD MANAGEMENT MARKET FOR OTHER REAGENTS, BY REGION, 2017–2024 (USD MILLION) 74
TABLE 48 PATIENT BLOOD MANAGEMENT SOFTWARE MARKET, BY TYPE 2017–2024 (USD MILLION) 75
TABLE 49 PATIENT BLOOD MANAGEMENT SOFTWARE MARKET, BY REGION 2017–2024 (USD MILLION) 75
TABLE 50 SOFTWARE MARKET SPLIT, BY COMPONENT 75
TABLE 51 SOFTWARE MARKET SPLIT, BY END USER 76
TABLE 52 BLOOD BANK AND TRANSFUSION MANAGEMENT SOFTWARE MARKET, BY REGION, 2017–2024 (USD MILLION) 77
TABLE 53 OTHER PATIENT BLOOD MANAGEMENT SOFTWARE MARKET, BY REGION 2017–2024 (USD MILLION) 77
TABLE 54 PATIENT BLOOD MANAGEMENT MARKET, BY COMPONENT 2017–2024 (USD MILLION) 79
TABLE 55 PATIENT BLOOD MANAGEMENT MARKET FOR WHOLE BLOOD, BY REGION 2017–2024 (USD MILLION) 80
TABLE 56 PATIENT BLOOD MANAGEMENT MARKET FOR BLOOD COMPONENTS, BY REGION, 2017–2024 (USD MILLION) 81
TABLE 57 PATIENT BLOOD MANAGEMENT MARKET, BY END USER 2017–2024 (USD MILLION) 83
TABLE 58 PATIENT BLOOD MANAGEMENT MARKET FOR BLOOD BANKS, BY REGION 2017–2024 (USD MILLION) 83
TABLE 59 PATIENT BLOOD MANAGEMENT MARKET FOR HOSPITALS, BY REGION 2017–2024 (USD MILLION) 84
TABLE 60 PATIENT BLOOD MANAGEMENT MARKET, BY REGION, 2017–2024 (USD MILLION) 86
TABLE 61 NORTH AMERICA: PATIENT BLOOD MANAGEMENT MARKET, BY COUNTRY 2017–2024 (USD MILLION) 88
TABLE 62 NORTH AMERICA: PATIENT BLOOD MANAGEMENT MARKET, BY PRODUCT 2017–2024 (USD MILLION) 88
TABLE 63 NORTH AMERICA: PATIENT BLOOD MANAGEMENT INSTRUMENTS MARKET BY TYPE, 2017–2024 (USD MILLION) 88
TABLE 64 NORTH AMERICA: PATIENT BLOOD MANAGEMENT ACCESSORIES MARKET BY TYPE, 2017–2024 (USD MILLION) 89
TABLE 65 NORTH AMERICA: PATIENT BLOOD MANAGEMENT REAGENTS & KITS MARKET BY TYPE, 2017–2024 (USD MILLION) 89
TABLE 66 NORTH AMERICA: PATIENT BLOOD MANAGEMENT SOFTWARE MARKET, BY TYPE, 2017–2024 (USD MILLION) 89
TABLE 67 US: PATIENT BLOOD MANAGEMENT MARKET, BY PRODUCT 2017–2024 (USD MILLION) 91
TABLE 68 US: PATIENT BLOOD MANAGEMENT INSTRUMENTS MARKET, BY TYPE 2017–2024 (USD MILLION) 91
TABLE 69 US: PATIENT BLOOD MANAGEMENT ACCESSORIES MARKET, BY TYPE 2017–2024 (USD MILLION) 91
TABLE 70 US: PATIENT BLOOD MANAGEMENT REAGENTS & KITS MARKET, BY TYPE 2017–2024 (USD MILLION) 92
TABLE 71 US: PATIENT BLOOD MANAGEMENT SOFTWARE MARKET, BY TYPE 2017–2024 (USD MILLION) 92
TABLE 72 CANADA: PATIENT BLOOD MANAGEMENT MARKET, BY PRODUCT 2017–2024 (USD MILLION) 93
TABLE 73 CANADA: PATIENT BLOOD MANAGEMENT INSTRUMENTS MARKET, BY TYPE 2017–2024 (USD MILLION) 94
TABLE 74 CANADA: PATIENT BLOOD MANAGEMENT ACCESSORIES MARKET, BY TYPE 2017–2024 (USD MILLION) 94
TABLE 75 CANADA: PATIENT BLOOD MANAGEMENT REAGENTS & KITS MARKET BY TYPE, 2017–2024 (USD MILLION) 94
TABLE 76 CANADA: PATIENT BLOOD MANAGEMENT SOFTWARE MARKET, BY TYPE 2017–2024 (USD MILLION) 95
TABLE 77 EUROPE: PATIENT BLOOD MANAGEMENT MARKET, BY COUNTRY 2017–2024 (USD MILLION) 96
TABLE 78 EUROPE: PATIENT BLOOD MANAGEMENT MARKET, BY PRODUCT 2017–2024 (USD MILLION) 96
TABLE 79 EUROPE: PATIENT BLOOD MANAGEMENT INSTRUMENTS MARKET, BY TYPE 2017–2024 (USD MILLION) 96
TABLE 80 EUROPE: PATIENT BLOOD MANAGEMENT ACCESSORIES MARKET, BY TYPE 2017–2024 (USD MILLION) 97
TABLE 81 EUROPE: PATIENT BLOOD MANAGEMENT REAGENTS & KITS MARKET, BY TYPE, 2017–2024 (USD MILLION) 97
TABLE 82 EUROPE: PATIENT BLOOD MANAGEMENT SOFTWARE MARKET, BY TYPE 2017–2024 (USD MILLION) 97
TABLE 83 GERMANY: PATIENT BLOOD MANAGEMENT MARKET, BY PRODUCT 2017–2024 (USD MILLION) 98
TABLE 84 GERMANY: PATIENT BLOOD MANAGEMENT INSTRUMENTS MARKET BY TYPE, 2017–2024 (USD MILLION) 98
TABLE 85 GERMANY: PATIENT BLOOD MANAGEMENT ACCESSORIES MARKET BY TYPE, 2017–2024 (USD MILLION) 99
TABLE 86 GERMANY: PATIENT BLOOD MANAGEMENT REAGENTS & KITS MARKET BY TYPE, 2017–2024 (USD MILLION) 99
TABLE 87 GERMANY: PATIENT BLOOD MANAGEMENT SOFTWARE MARKET, BY TYPE 2017–2024 (USD MILLION) 99
TABLE 88 UK: PATIENT BLOOD MANAGEMENT MARKET, BY PRODUCT 2017–2024 (USD MILLION) 100
TABLE 89 UK: PATIENT BLOOD MANAGEMENT INSTRUMENTS MARKET, BY TYPE 2017–2024 (USD MILLION) 101
TABLE 90 UK: PATIENT BLOOD MANAGEMENT ACCESSORIES MARKET, BY TYPE 2017–2024 (USD MILLION) 101
TABLE 91 UK: PATIENT BLOOD MANAGEMENT REAGENTS & KITS MARKET, BY TYPE 2017–2024 (USD MILLION) 101
TABLE 92 UK: PATIENT BLOOD MANAGEMENT SOFTWARE MARKET, BY TYPE 2017–2024 (USD MILLION) 102
TABLE 93 FRANCE: PATIENT BLOOD MANAGEMENT MARKET, BY PRODUCT 2017–2024 (USD MILLION) 102
TABLE 94 FRANCE: PATIENT BLOOD MANAGEMENT INSTRUMENTS MARKET, BY TYPE 2017–2024 (USD MILLION) 103
TABLE 95 FRANCE: PATIENT BLOOD MANAGEMENT ACCESSORIES MARKET, BY TYPE 2017–2024 (USD MILLION) 103
TABLE 96 FRANCE: PATIENT BLOOD MANAGEMENT REAGENTS & KITS MARKET, BY TYPE, 2017–2024 (USD MILLION) 103
TABLE 97 FRANCE: PATIENT BLOOD MANAGEMENT SOFTWARE MARKET, BY TYPE 2017–2024 (USD MILLION) 104
TABLE 98 ITALY: PATIENT BLOOD MANAGEMENT MARKET, BY PRODUCT 2017–2024 (USD MILLION) 104
TABLE 99 ITALY: PATIENT BLOOD MANAGEMENT INSTRUMENTS MARKET, BY TYPE 2017–2024 (USD MILLION) 105
TABLE 100 ITALY: PATIENT BLOOD MANAGEMENT ACCESSORIES MARKET, BY TYPE 2017–2024 (USD MILLION) 105
TABLE 101 ITALY: PATIENT BLOOD MANAGEMENT REAGENTS & KITS MARKET, BY TYPE, 2017–2024 (USD MILLION) 105
TABLE 102 ITALY: PATIENT BLOOD MANAGEMENT SOFTWARE MARKET, BY TYPE 2017–2024 (USD MILLION) 106
TABLE 103 SPAIN: PATIENT BLOOD MANAGEMENT MARKET, BY PRODUCT 2017–2024 (USD MILLION) 106
TABLE 104 SPAIN: PATIENT BLOOD MANAGEMENT INSTRUMENTS MARKET, BY TYPE 2017–2024 (USD MILLION) 107
TABLE 105 SPAIN: PATIENT BLOOD MANAGEMENT ACCESSORIES MARKET, BY TYPE 2017–2024 (USD MILLION) 107
TABLE 106 SPAIN: PATIENT BLOOD MANAGEMENT REAGENTS & KITS MARKET, BY TYPE, 2017–2024 (USD MILLION) 107
TABLE 107 SPAIN: PATIENT BLOOD MANAGEMENT SOFTWARE MARKET, BY TYPE 2017–2024 (USD MILLION) 108
TABLE 108 ROE: PATIENT BLOOD MANAGEMENT MARKET, BY PRODUCT 2017–2024 (USD MILLION) 108
TABLE 109 ROE: PATIENT BLOOD MANAGEMENT INSTRUMENTS MARKET, BY TYPE 2017–2024 (USD MILLION) 109
TABLE 110 ROE: PATIENT BLOOD MANAGEMENT ACCESSORIES MARKET, BY TYPE 2017–2024 (USD MILLION) 109
TABLE 111 ROE: PATIENT BLOOD MANAGEMENT REAGENTS & KITS MARKET, BY TYPE 2017–2024 (USD MILLION) 109
TABLE 112 ROE: PATIENT BLOOD MANAGEMENT SOFTWARE MARKET, BY TYPE 2017–2024 (USD MILLION) 110
TABLE 113 ASIA PACIFIC: PATIENT BLOOD MANAGEMENT MARKET, BY COUNTRY 2017–2024 (USD MILLION) 112
TABLE 114 ASIA PACIFIC: PATIENT BLOOD MANAGEMENT MARKET, BY PRODUCT 2017–2024 (USD MILLION) 112
TABLE 115 ASIA PACIFIC: PATIENT BLOOD MANAGEMENT INSTRUMENTS MARKET BY TYPE, 2017–2024 (USD MILLION) 112
TABLE 116 ASIA PACIFIC: PATIENT BLOOD MANAGEMENT ACCESSORIES MARKET BY TYPE, 2017–2024 (USD MILLION) 113
TABLE 117 ASIA PACIFIC: PATIENT BLOOD MANAGEMENT REAGENTS & KITS MARKET BY TYPE, 2017–2024 (USD MILLION) 113
TABLE 118 ASIA PACIFIC: PATIENT BLOOD MANAGEMENT SOFTWARE MARKET BY TYPE, 2017–2024 (USD MILLION) 113
TABLE 119 JAPAN: PATIENT BLOOD MANAGEMENT MARKET, BY PRODUCT 2017–2024 (USD MILLION) 114
TABLE 120 JAPAN: PATIENT BLOOD MANAGEMENT INSTRUMENTS MARKET, BY TYPE 2017–2024 (USD MILLION) 115
TABLE 121 JAPAN: PATIENT BLOOD MANAGEMENT ACCESSORIES MARKET, BY TYPE 2017–2024 (USD MILLION) 115
TABLE 122 JAPAN: PATIENT BLOOD MANAGEMENT REAGENTS & KITS MARKET BY TYPE, 2017–2024 (USD MILLION) 115
TABLE 123 JAPAN: PATIENT BLOOD MANAGEMENT SOFTWARE MARKET, BY TYPE 2017–2024 (USD MILLION) 116
TABLE 124 CHINA: PATIENT BLOOD MANAGEMENT MARKET, BY PRODUCT 2017–2024 (USD MILLION) 116
TABLE 125 CHINA: PATIENT BLOOD MANAGEMENT INSTRUMENTS MARKET, BY TYPE 2017–2024 (USD MILLION) 117
TABLE 126 CHINA: PATIENT BLOOD MANAGEMENT ACCESSORIES MARKET, BY TYPE 2017–2024 (USD MILLION) 117
TABLE 127 CHINA: PATIENT BLOOD MANAGEMENT REAGENTS & KITS MARKET, BY TYPE, 2017–2024 (USD MILLION) 117
TABLE 128 CHINA: PATIENT BLOOD MANAGEMENT SOFTWARE MARKET, BY TYPE 2017–2024 (USD MILLION) 118
TABLE 129 INDIA: PATIENT BLOOD MANAGEMENT MARKET, BY PRODUCT 2017–2024 (USD MILLION) 118
TABLE 130 INDIA: PATIENT BLOOD MANAGEMENT INSTRUMENTS MARKET, BY TYPE 2017–2024 (USD MILLION) 119
TABLE 131 INDIA: PATIENT BLOOD MANAGEMENT ACCESSORIES MARKET, BY TYPE 2017–2024 (USD MILLION) 119
TABLE 132 INDIA: PATIENT BLOOD MANAGEMENT REAGENTS & KITS MARKET, BY TYPE, 2017–2024 (USD MILLION) 119
TABLE 133 INDIA: PATIENT BLOOD MANAGEMENT SOFTWARE MARKET, BY TYPE 2017–2024 (USD MILLION) 120
TABLE 134 AUSTRALIA: PATIENT BLOOD MANAGEMENT MARKET, BY PRODUCT 2017–2024 (USD MILLION) 120
TABLE 135 AUSTRALIA: PATIENT BLOOD MANAGEMENT INSTRUMENTS MARKET, BY TYPE, 2017–2024 (USD MILLION) 121
TABLE 136 AUSTRALIA: PATIENT BLOOD MANAGEMENT ACCESSORIES MARKET, BY TYPE, 2017–2024 (USD MILLION) 121
TABLE 137 AUSTRALIA: PATIENT BLOOD MANAGEMENT REAGENTS & KITS MARKET, BY TYPE, 2017–2024 (USD MILLION) 121
TABLE 138 AUSTRALIA: PATIENT BLOOD MANAGEMENT SOFTWARE MARKET, BY TYPE 2017–2024 (USD MILLION) 122
TABLE 139 SOUTH KOREA: PATIENT BLOOD MANAGEMENT MARKET, BY PRODUCT 2017–2024 (USD MILLION) 122
TABLE 140 SOUTH KOREA: PATIENT BLOOD MANAGEMENT INSTRUMENTS MARKET, BY TYPE, 2017–2024 (USD MILLION) 123
TABLE 141 SOUTH KOREA: PATIENT BLOOD MANAGEMENT ACCESSORIES MARKET, BY TYPE, 2017–2024 (USD MILLION) 123
TABLE 142 SOUTH KOREA: PATIENT BLOOD MANAGEMENT REAGENTS & KITS MARKET BY TYPE, 2017–2024 (USD MILLION) 123
TABLE 143 SOUTH KOREA: PATIENT BLOOD MANAGEMENT SOFTWARE MARKET, BY TYPE, 2017–2024 (USD MILLION) 124
TABLE 144 ROAPAC: PATIENT BLOOD MANAGEMENT MARKET, BY PRODUCT, 2017–2024 (USD MILLION) 124
TABLE 145 ROAPAC: PATIENT BLOOD MANAGEMENT INSTRUMENTS MARKET, BY TYPE 2017–2024 (USD MILLION) 125
TABLE 146 ROAPAC: PATIENT BLOOD MANAGEMENT ACCESSORIES MARKET, BY TYPE 2017–2024 (USD MILLION) 125
TABLE 147 ROAPAC: PATIENT BLOOD MANAGEMENT REAGENTS & KITS MARKET, BY TYPE, 2017–2024 (USD MILLION) 125
TABLE 148 ROAPAC: PATIENT BLOOD MANAGEMENT SOFTWARE MARKET, BY TYPE 2017–2024 (USD MILLION) 126
TABLE 149 LATIN AMERICA: PATIENT BLOOD MANAGEMENT MARKET, BY COUNTRY 2017–2024 (USD MILLION) 126
TABLE 150 LATIN AMERICA: PATIENT BLOOD MANAGEMENT MARKET, BY PRODUCT 2017–2024 (USD MILLION) 127
TABLE 151 LATIN AMERICA: PATIENT BLOOD MANAGEMENT INSTRUMENTS MARKET, BY TYPE, 2017–2024 (USD MILLION) 127
TABLE 152 LATIN AMERICA: PATIENT BLOOD MANAGEMENT ACCESSORIES MARKET, BY TYPE, 2017–2024 (USD MILLION) 127
TABLE 153 LATIN AMERICA: PATIENT BLOOD MANAGEMENT REAGENTS & KITS MARKET BY TYPE, 2017–2024 (USD MILLION) 128
TABLE 154 LATIN AMERICA: PATIENT BLOOD MANAGEMENT SOFTWARE MARKET, BY TYPE, 2017–2024 (USD MILLION) 128
TABLE 155 BRAZIL: PATIENT BLOOD MANAGEMENT MARKET, BY PRODUCT 2017–2024 (USD MILLION) 129
TABLE 156 BRAZIL: PATIENT BLOOD MANAGEMENT INSTRUMENTS MARKET, BY TYPE 2017–2024 (USD MILLION) 129
TABLE 157 BRAZIL: PATIENT BLOOD MANAGEMENT ACCESSORIES MARKET, BY TYPE 2017–2024 (USD MILLION) 129
TABLE 158 BRAZIL: PATIENT BLOOD MANAGEMENT REAGENTS & KITS MARKET BY TYPE, 2017–2024 (USD MILLION) 130
TABLE 159 BRAZIL: PATIENT BLOOD MANAGEMENT SOFTWARE MARKET, BY TYPE 2017–2024 (USD MILLION) 130
TABLE 160 MEXICO: PATIENT BLOOD MANAGEMENT MARKET, BY PRODUCT 2017–2024 (USD MILLION) 131
TABLE 161 MEXICO: PATIENT BLOOD MANAGEMENT INSTRUMENTS MARKET, BY TYPE 2017–2024 (USD MILLION) 131
TABLE 162 MEXICO: PATIENT BLOOD MANAGEMENT ACCESSORIES MARKET, BY TYPE 2017–2024 (USD MILLION) 131
TABLE 163 MEXICO: PATIENT BLOOD MANAGEMENT REAGENTS & KITS MARKET, BY TYPE, 2017–2024 (USD MILLION) 132
TABLE 164 MEXICO: PATIENT BLOOD MANAGEMENT SOFTWARE MARKET, BY TYPE 2017–2024 (USD MILLION) 132
TABLE 165 ROLA: PATIENT BLOOD MANAGEMENT MARKET, BY PRODUCT 2017–2024 (USD MILLION) 133
TABLE 166 ROLA: PATIENT BLOOD MANAGEMENT INSTRUMENTS MARKET, BY TYPE 2017–2024 (USD MILLION) 133
TABLE 167 ROLA: PATIENT BLOOD MANAGEMENT ACCESSORIES MARKET, BY TYPE 2017–2024 (USD MILLION) 133
TABLE 168 ROLA: PATIENT BLOOD MANAGEMENT REAGENTS & KITS MARKET, BY TYPE, 2017–2024 (USD MILLION) 134
TABLE 169 ROLA: PATIENT BLOOD MANAGEMENT SOFTWARE MARKET, BY TYPE 2017–2024 (USD MILLION) 134
TABLE 170 MEA: PATIENT BLOOD MANAGEMENT MARKET, BY PRODUCT 2017–2024 (USD MILLION) 135
TABLE 171 MEA: PATIENT BLOOD MANAGEMENT INSTRUMENTS MARKET, BY TYPE 2017–2024 (USD MILLION) 135
TABLE 172 MEA: PATIENT BLOOD MANAGEMENT ACCESSORIES MARKET, BY TYPE 2017–2024 (USD MILLION) 135
TABLE 173 MEA: PATIENT BLOOD MANAGEMENT REAGENTS & KITS MARKET, BY TYPE 2017–2024 (USD MILLION) 136
TABLE 174 MEA: PATIENT BLOOD MANAGEMENT SOFTWARE MARKET, BY TYPE 2017–2024 (USD MILLION) 136